09 Oct Long Term Treatment With Dabigatran Reduces Alzheimer’s Symptoms in Mouse Model
Long-term treatment with an oral direct anticoagulant ameliorates Alzheimer´s disease pathogenesis in a mouse model of the disease.
03 Oct Wistar Researchers Identify Mitochondrial Factor That Keeps Cancer Cells Alive
MedicalResearch.com Interview with: Ekta Agarwal, Ph.D. Postdoctoral fellow in the lab of Dario Altieri, M.D. Wistar president and CEO ,Director...
25 Sep Apple Cider Vinegar Soaks Did Not Improve Skin Barrier in Atopic Dermatitis – Eczema
There was no change after the 2 weeks of apple cider vinegar soaks in the “skin barrier function” which we measured as the amount of water lost from the skin
24 Sep Increased Hypertension Risk in Patients With Periodontitis – Gum Disease
Looking after oral health is often neglected and instead should be considered as important as managing other general health problems.
24 Sep Bispecific Inhibitor Helps Overcome Pancreatic Cancer Drug Resistance
While novel immunotherapies and target cancer therapies have shown promising results, the percentage of patients responding to single-agent checkpoint inhibitor drugs is only 12.46% on average for all tumor types.
16 Sep Atopic Dermatitis: Antibiotic Choice in Pediatric Superinfections
Systemic therapy for pediatric atopic dermatitis is advancing
08 Sep THEMIS-PCI Trial: Ticagrelor in Patients with Diabetes and Stable CAD with History of PCI
Posted at 00:30h
in Author Interviews, Brigham & Women's - Harvard, Clots - Coagulation, Diabetes, Heart Disease, Lancet
In carefully selected patients with diabetes and stable coronary artery disease who have a history of previous coronary stenting and have presumably tolerated DAPT in the past without bleeding complications, the combination of ticagrelor plus low-dose aspirin should be considered.
06 Sep Bacterial Microbiome Could Enhance Effects of Metformin
Our research opens up the avenue for the development of specific dietary guidelines or even genetically modified bacteria that could enhance the effects of metformin and reduce its side-effects.
21 Aug Meaningful PTSD Improvement Associated with Lower Risk of Diabetes
Patients may consider the secondary health benefits when deciding to complete PTSD psychotherapy.
19 Aug Lavender Oil Linked to Abnormal Breast Development in Girls and Boys
It is still unknown why a small portion of these children experience abnormal, early breast growth and others are unaffected.
16 Aug Men With Dementia More Likely to Receive Aggressive Care at End of Life
Our study findings suggest that this gender bias may persist at the end of life, when more aggressive care—something that may have been valued at a younger age—is still provided despite such care no longer being necessarily optimal.
14 Aug FDA Identifies No New Safety Concerns Associated with Prostate Cancer Treatment Vaccine Sipuleucel-T
While this is the largest post-marketing study of safety and sipuleucel-T, our results should be considered in the context of study limitations.
11 Aug Nanovaccine Opens New Approach to Melanoma Treatment
We believe that vaccination will play an important role in cancer therapies in the future, particularly in modulating the patients’ own immune system, turning it into its functional state
06 Aug Treatment and Recovery Services Appear Particularly Important For Sustained Recovery in Opioid Addiction
Our findings suggests that an estimated 1.18 million American adults have resolved a primary opioid use problem.
05 Aug Application of Romulus and Remus Hypothesis Can Help Autistic Children Improve Language Skills
The Romulus and Remus hypothesis cannot be tested in extinct hominins, but can be applied to children who don’t naturally acquire full recursive language.
27 Jul Can We Learn From Advice We Would Give Our Younger Selves?
While people should not wallow in the past, it’s important to think about the advice we would offer our younger selves
18 Jul Older Patients May Benefit from Combination of Simvastatin-Ezetimibe After Acute Coronary Syndrome
Our data show that elderly patients after an acute coronary syndrome may derive significant benefit with preserved safety from higher-intensity lipid-lowering therapy with ezetimibe-simvastatin versus simvastatin alone
17 Jul HIV Incidence: Effect of Universal Testing and Treatment
Delivery of an HIV prevention strategy that includes offering in-home HIV testing to everyone, with immediate referral to HIV care, and rapid initiation of treatment for people living with HIV, can substantially reduce new HIV infections
28 Jun Spirometry Threshold Establishes Diagnosis of Clinically Significant COPD
our study supports the continued use of spirometry – a non-invasive, cost-effective, reliable breathing test – for diagnosing airflow obstruction in COPD.
24 Jun COLVERA™ Blood Test Provides Improved Effectiveness Detecting Recurrence of Colorectal Cancer
The presentation outlined a research study comparing the effectiveness of COLVERA™, an innovative genomic test, with the standard of care blood-based test for detection of carcinoembryonic antigen (CEA), for monitoring colorectal cancer (CRC) recurrence.
23 Jun REMfresh Study of Continuous Release Melatonin Demonstrated Improved Sleep Duration and Quality
These latest findings provide further confirmation of the potential for nonprescription REMfresh to help address the public health issue of the cumulative effects of sleep loss.
10 Jun Cardiac Radiation Can Increase Mortality in Lung Cancer Patients
Posted at 19:34h
in Author Interviews, Brigham & Women's - Harvard, Heart Disease, JACC, Lung Cancer, Radiation Therapy
We found that despite a high competing risk of death from lung cancer, cardiac radiation dose exposure is a modifiable cardiac risk factor for Major Adverse Cardiac Events and mortality.
03 Jun SPARTAN Study: Older Castration-Resistant Prostate Cancer Patients Can Tolerate and Benefit from Apalutamide (ERLEADA®)
Younger patients tended to have more aggressive disease features but better performance status.
03 Jun CLL: Ibrutinib (IMBRUVICA®) Demonstrated Durable Responses for High Risk Patients
Based on this study and others, Ibrutinib remains an excellent treatment option for this population and for CLL patients receiving first line therapy.
03 Jun Novartis Piqray® Approved for Patients with a PIK3CA Mutation in HR+/HER2- Advanced Breast Cancer
https://www.novartis.com/news/media-releases/fda-approves-novartis-piqray-first-and-only-treatment-specifically-patients-pik3ca-mutation-hrher2-advanced-breast-cancer
02 Jun Circulating DNA Can Indicate Melanoma Treatment Failure
We think that detectable ctDNA after 4 weeks of treatment was evidence of less effective drug treatment,
28 May Study Finds You Don’t Have To Fast Before Getting Your Lipids Measured
These results should reassure healthcare providers that fasting prior to a lipid test is not necessary, regardless of whether the lipid test is done prior to or during statin treatment.
22 May BrainHQ Computerized Training Program Improved Cognitive Parameters after Mild TBI
There are now more than 150 peer-reviewed articles on the benefits of the exercises and assessments in BrainHQ.